Condition

Core Binding Factor Acute Myeloid Leukemia clinical trials and research

• 2Clinical trials
• 3Countries

All recruiting trials (2)

• Venetoclax or GO added to standard chemotherapy for CBF-AML

  This phase 2 trial tests whether adding venetoclax or gemtuzumab ozogamicin to the usual cytarabine/daunorubicin regimen helps people with core-binding factor AML achieve higher complete remissions without residual disease.

  Recruiting at 81 sites Phase 2 National Cancer Institute (NCI) · Birmingham, Alabama and 80 other locations · NCT06917911

• Using Avapritinib to treat relapsed or refractory pediatric CBF-AML with KIT mutation

  This study is testing if a new drug called avapritinib can help children with a specific type of leukemia that keeps coming back and has a certain mutation, to see if it works better than the treatments they currently have.

  Recruiting Phase 2 Children's Hospital of Soochow University · Hefei, Anhui and 11 other locations · NCT06316960

Related topics

Quick answers

How many Core Binding Factor Acute Myeloid Leukemia clinical trials are recruiting right now?

2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 3 countries. The most sites are in China (1 trial), Puerto Rico (1 trial), United States (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 2. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →